StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2024 - 03 - 28
3
2024 - 03 - 18
3
2024 - 02 - 22
3
2024 - 02 - 12
4
2023 - 12 - 22
4
2023 - 12 - 12
3
2023 - 10 - 31
3
2023 - 10 - 17
3
2023 - 09 - 26
3
2023 - 09 - 22
4
2023 - 06 - 08
3
2023 - 05 - 30
3
2023 - 05 - 01
3
2023 - 04 - 05
3
2023 - 02 - 02
3
2023 - 01 - 27
3
2022 - 08 - 10
3
2022 - 06 - 06
3
2022 - 06 - 03
3
2022 - 06 - 02
3
2022 - 04 - 12
4
2022 - 04 - 05
3
2022 - 02 - 25
3
2021 - 11 - 12
3
2021 - 11 - 03
3
2021 - 10 - 01
3
2021 - 09 - 17
3
2021 - 09 - 16
3
2021 - 09 - 08
3
2021 - 08 - 19
3
2021 - 07 - 30
3
2021 - 07 - 09
3
2021 - 06 - 25
3
2021 - 06 - 17
3
2021 - 06 - 10
5
2021 - 06 - 04
3
2021 - 05 - 24
3
2021 - 05 - 20
5
2021 - 05 - 19
3
2021 - 05 - 18
4
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 29
3
2021 - 04 - 28
4
2021 - 04 - 23
5
2021 - 04 - 22
2
2021 - 04 - 16
4
2021 - 04 - 14
3
2021 - 04 - 13
3
2021 - 04 - 12
2
2021 - 04 - 07
3
2021 - 03 - 25
2
2021 - 03 - 19
3
2021 - 03 - 11
2
2021 - 03 - 04
2
2021 - 01 - 20
2
2021 - 01 - 11
2
2021 - 01 - 04
2
2020 - 12 - 11
3
2020 - 12 - 08
2
Sector
Health technology
4
Tags
Approval
3
Cancer
4
Drug
1
Fda
2
Fda approval
2
Food
1
Immunotherapy
1
N/a
3
Nivolumab
2
Product-news
1
Therapy
1
Treatment
1
Entities
Abbvie inc.
1
Agios pharmaceuticals, inc.
1
Alnylam pharmaceuticals, inc.
1
Amgen inc.
1
Aveo pharmaceuticals, inc.
1
Beigene, ltd.
1
Blueprint medicines corporation
1
Bristol-myers squibb company
4
Clovis oncology, inc.
1
Eli lilly and company
1
Epizyme, inc.
1
Exelixis, inc.
1
Illumina, inc.
1
Incyte corporation
1
Karyopharm therapeutics inc.
1
Pfizer, inc.
1
Regeneron pharmaceuticals, inc.
1
Rigel pharmaceuticals, inc.
1
Sanofi
1
Verastem, inc.
1
Y-mabs therapeutics, inc.
1
Symbols
AAPL
1
ABB
1
ABBV
2
ABMD
1
ABT
3
ACB
1
ACGL
1
ADSK
1
ADVM
1
AEM
1
AFYA
1
AGIO
1
AKRO
1
ALGM
1
ALK
1
ALLY
1
ALNY
1
AMCX
2
AMED
1
AMGN
2
AMPG
1
AMZN
3
ARVL
2
AVEO
2
BALY
3
BK
2
BMEA
2
BMY
4
CDNA
2
CERN
2
CM
2
CMCSA
2
DOW
2
EH
2
ENB
3
GE
2
GOOG
2
GOOGL
2
HON
2
HZNP
2
IBM
2
ILMN
2
INTC
2
JNJ
11
LH
2
LLY
3
MDT
2
MDXG
2
MS
7
MSFT
3
NRIX
2
PHG
2
PYPL
2
SNY
6
SPNE
2
SYBX
2
T
2
TNP
3
XYF
2
YELL
3
Exchanges
Nasdaq
1
Nyse
4
Crawled Date
2021 - 04 - 16
4
Crawled Time
17:00
1
18:04
2
19:00
1
Source
www.biospace.com
1
www.fda.gov
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 04 - 16
symbols :
Bmy
save search
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
Published:
2021-04-16
(Crawled : 19:00)
- biospace.com/
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.07%
|
O:
0.76%
H:
1.09%
C:
0.82%
food
therapy
cancer
drug
nivolumab
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Published:
2021-04-16
(Crawled : 18:04)
- fda.gov
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.07%
|
O:
0.76%
H:
1.09%
C:
0.82%
cancer
fda
fda approval
approval
nivolumab
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-04-16
(Crawled : 18:04)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-30.85%
|
O:
0.72%
H:
2.19%
C:
1.85%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
290.66%
|
O:
0.79%
H:
1.56%
C:
1.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.07%
|
O:
0.76%
H:
1.09%
C:
0.82%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
55.68%
|
O:
0.56%
H:
0.99%
C:
0.39%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-44.58%
|
O:
1.5%
H:
0.22%
C:
-5.38%
VSTM
|
$9.86
-3.62%
-3.75%
150K
|
Health Technology
|
265.8%
|
O:
1.12%
H:
0.0%
C:
-1.47%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.66%
|
O:
0.59%
H:
0.96%
C:
0.61%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-71.43%
|
O:
0.26%
H:
0.0%
C:
-5.54%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
81.31%
|
O:
0.41%
H:
2.06%
C:
1.2%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-87.93%
|
O:
-0.26%
H:
2.95%
C:
0.47%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-37.08%
|
O:
0.5%
H:
0.3%
C:
-1.12%
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
-70.79%
|
O:
-0.02%
H:
0.12%
C:
-0.72%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-5.97%
|
O:
-0.17%
H:
0.84%
C:
-1.34%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.14%
|
O:
0.97%
H:
0.24%
C:
-2.59%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.59%
|
O:
-0.66%
H:
1.16%
C:
-1.32%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-9.48%
|
O:
1.16%
H:
0.0%
C:
-1.92%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-57.92%
|
O:
-0.07%
H:
0.18%
C:
-0.67%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
138.02%
|
O:
-0.95%
H:
0.16%
C:
-0.48%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
5.41%
|
O:
0.51%
H:
0.93%
C:
-0.28%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
3.88%
|
O:
0.41%
H:
0.34%
C:
-0.51%
AGIO
|
$29.52
0.31%
0.3%
750K
|
Health Technology
|
-46.35%
|
O:
-0.45%
H:
2.17%
C:
-0.18%
cancer
approval
FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Published:
2021-04-16
(Crawled : 17:00)
- fda.gov
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.07%
|
O:
0.76%
H:
1.09%
C:
0.82%
cancer
treatment
fda
approval
fda approval
immunotherapy
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.